These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
361 related items for PubMed ID: 19413638
1. Clusterin expression in cholestasis, hepatocellular carcinoma and liver fibrosis. Aigelsreiter A, Janig E, Sostaric J, Pichler M, Unterthor D, Halasz J, Lackner C, Zatloukal K, Denk H. Histopathology; 2009 Apr; 54(5):561-70. PubMed ID: 19413638 [Abstract] [Full Text] [Related]
2. [Selective deposition of agrin in the microvasculature of hepatocellular carcinoma: aspects in pathogenesis and differential diagnosis]. Tátrai P. Magy Onkol; 2008 Dec; 52(4):379-83. PubMed ID: 19068466 [Abstract] [Full Text] [Related]
4. CHOP deficiency attenuates cholestasis-induced liver fibrosis by reduction of hepatocyte injury. Tamaki N, Hatano E, Taura K, Tada M, Kodama Y, Nitta T, Iwaisako K, Seo S, Nakajima A, Ikai I, Uemoto S. Am J Physiol Gastrointest Liver Physiol; 2008 Feb; 294(2):G498-505. PubMed ID: 18174271 [Abstract] [Full Text] [Related]
6. [Epithelial-mesenchymal transition of biliary epithelial cells in advanced liver fibrosis]. Schulze F, Schardt K, Wedemeyer I, Konze E, Wendland K, Dirsch O, Töx U, Dienes HP, Odenthal M. Verh Dtsch Ges Pathol; 2007 Feb; 91():250-6. PubMed ID: 18314622 [Abstract] [Full Text] [Related]
7. Synemin expression is widespread in liver fibrosis and is induced in proliferating and malignant biliary epithelial cells. Schmitt-Graeff A, Jing R, Nitschke R, Desmoulière A, Skalli O. Hum Pathol; 2006 Sep; 37(9):1200-10. PubMed ID: 16938526 [Abstract] [Full Text] [Related]
8. Expression of bcl-2 in ductular proliferation is related to periportal hepatic stellate cell activation and fibrosis progression in patients with autoimmune cholestasis. Sánchez-Muñoz D, Castellano-Megías VM, Romero-Gómez M. Dig Liver Dis; 2007 Mar; 39(3):262-6. PubMed ID: 17270507 [Abstract] [Full Text] [Related]
9. Expression and immunogenicity of NY-ESO-1 in hepatocellular carcinoma. Nakamura S, Nouso K, Noguchi Y, Higashi T, Ono T, Jungbluth A, Chen YT, Old LJ, Nakayama E, Shiratori Y. J Gastroenterol Hepatol; 2006 Aug; 21(8):1281-5. PubMed ID: 16872310 [Abstract] [Full Text] [Related]
10. Hepatoma in familial cholestatic cirrhosis of childhood: its occurrence in twin brothers. Dahms BB. Arch Pathol Lab Med; 1979 Jan; 103(1):30-3. PubMed ID: 215101 [Abstract] [Full Text] [Related]
11. Expression of the extracellular matrix protein periostin in liver tumours and bile duct carcinomas. Riener MO, Fritzsche FR, Soll C, Pestalozzi BC, Probst-Hensch N, Clavien PA, Jochum W, Soltermann A, Moch H, Kristiansen G. Histopathology; 2010 Apr; 56(5):600-6. PubMed ID: 20459570 [Abstract] [Full Text] [Related]
12. Expression of cytokeratin 19 in human hepatocellular carcinoma cell lines. Wu F, Nishioka M, Fujita J, Murota M, Ohtsuki Y, Ishida T, Kuriyama S. Int J Oncol; 2002 Jan; 20(1):31-7. PubMed ID: 11743639 [Abstract] [Full Text] [Related]
14. Immunohistochemical localization of endothelin-1/big endothelin-1 in normal liver, liver cirrhosis and hepatocellular carcinoma. Suzuki T, Hoshi N, Watanabe K, Kasukawa R, Suzuki T. Fukushima J Med Sci; 1998 Dec; 44(2):93-105. PubMed ID: 10091381 [Abstract] [Full Text] [Related]
15. Gene expression profiling in whole liver of bile duct ligated rats: VEGF-A expression is up-regulated in hepatocytes adjacent to the portal tracts. Tanaka A, Tsuneyama K, Mikami M, Uegaki S, Aiso M, Takikawa H. J Gastroenterol Hepatol; 2007 Nov; 22(11):1993-2000. PubMed ID: 17914982 [Abstract] [Full Text] [Related]
16. Sodium iodide symporter is expressed at the preneoplastic stages of liver carcinogenesis and in human cholangiocarcinoma. Liu B, Hervé J, Bioulac-Sage P, Valogne Y, Roux J, Yilmaz F, Boisgard R, Guettier C, Calès P, Tavitian B, Samuel D, Clerc J, Bréchot C, Faivre J. Gastroenterology; 2007 Apr; 132(4):1495-503. PubMed ID: 17408651 [Abstract] [Full Text] [Related]
17. Expression of the transcription factor Klf6 in cirrhosis, macronodules, and hepatocellular carcinoma. Bureau C, Péron JM, Bouisson M, Danjoux M, Selves J, Bioulac-Sage P, Balabaud C, Torrisani J, Cordelier P, Buscail L, Vinel JP. J Gastroenterol Hepatol; 2008 Jan; 23(1):78-86. PubMed ID: 18171345 [Abstract] [Full Text] [Related]
18. Expression of augmenter of liver regeneration (ALR) in human liver cirrhosis and carcinoma. Thasler WE, Schlott T, Thelen P, Hellerbrand C, Bataille F, Lichtenauer M, Schlitt HJ, Jauch KW, Weiss TS. Histopathology; 2005 Jul; 47(1):57-66. PubMed ID: 15982324 [Abstract] [Full Text] [Related]
19. Survivin gene expression in chronic liver disease and hepatocellular carcinoma. Montorsi M, Maggioni M, Falleni M, Pellegrini C, Donadon M, Torzilli G, Santambrogio R, Spinelli A, Coggi G, Bosari S. Hepatogastroenterology; 2007 Jul; 54(79):2040-4. PubMed ID: 18251156 [Abstract] [Full Text] [Related]
20. Comparison of the expression of agrin, a basement membrane heparan sulfate proteoglycan, in cholangiocarcinoma and hepatocellular carcinoma. Batmunkh E, Tátrai P, Szabó E, Lódi C, Holczbauer A, Páska C, Kupcsulik P, Kiss A, Schaff Z, Kovalszky I. Hum Pathol; 2007 Oct; 38(10):1508-15. PubMed ID: 17640714 [Abstract] [Full Text] [Related] Page: [Next] [New Search]